From tremors to triumph: one man's Parkinson's success story
Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...
AbbVie’s third successful Parkinson’s trial sets the stage for an eventful 2025
AbbVie Inc. announced positive data from a third late-stage trial of a treatment for Parkinson’s disease on Monday and said ...
Hope for Parkinson’s disease symptoms is found in late-stage drug study
Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...
STAT4d
Do GLP-1s work for Parkinson’s? A health tech startup pitches pharma on quick answers
Why digital measurements startup Koneksa Health thinks it can help pharma measure if their drugs are effective in people with ...
McKnight's Long-Term Care News2d
Parkinson’s advocates, groups hail EPA’s trichloroethylene ban
The US Environmental Protection Agency (EPA) disclosed Monday that it banned nearly all uses of trichloroethylene (TCE) — an ...
Research teams make progress against Parkinson's origins and effects
Two teams of scientists have recently come up with potential breakthroughs with preventing a serious side effect of Parkinson ...
BlackDoctor4d
Oschner Health Is Taking on First-of-Its-Kind Black Parkinson’s Research
The new Ochsner site will contribute to uncovering additional genes as well as examine health disparities and care access for ...
An Augmented Reality Program Can Help Patients Overcome Parkinson’s Symptoms
Simple external cues, such as lines on the floor, can help Parkinson’s patients focus their efforts and overcome the ...
Ask the doctors: Parkinson’s disease can cause swolling issues
Parkinson’s disease is a progressive neurological disorder in which ongoing changes in the brain affect and interfere with ...
Scientists Identify Protein That Could Alleviate Parkinson’s Disease
A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...